Cas:28166-41-8 α-Cyano-4-hydroxycinnamic acid manufacturer & supplier

Chemical Name:α-Cyano-4-hydroxycinnamic acid

CAS.NO:28166-41-8

Synonyms:(2E)-2-Cyano-3-(4-hydroxyphenyl)acrylic acid;Ganaxolone;2-Propenoic acid, 2-cyano-3-(4-hydroxyphenyl)-, (2E)-;4-HCCA;α-cyano-4-hydroxycinnamic acid;2-Cyano-3-(4-hydroxyphenyl)acrylic Acid;alpha-Cyano-4-hydroxycinnamic acid;MFCD00004204;(2E)-2-cyano-3-(4-hydroxyphenyl)prop-2-enoic acid;EINECS 248-879-1;A-CYANO-4-HYDROXYCINNAMIC ACID;ACCA

Molecular Formula:C₁₀H₇NO₃

Molecular Weight:189.167

HS Code:2926909090

Physical and Chemical Properties:

Melting point:245-250 °C(lit.)

Boiling point:398.1±32.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.674

PSA:81.32000

Exact Mass:189.042587

LogP:1.53

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like (2E)-2-Cyano-3-(4-hydroxyphenyl)acrylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ACCA physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Propenoic acid, 2-cyano-3-(4-hydroxyphenyl)-, (2E)- Use and application,ACCA technical grade,usp/ep/jp grade.

Related News: The United States has suspended imports of dogs from more than 100 countries where there’s a high rabies risk. α-Cyano-4-hydroxycinnamic acid manufacturer Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. α-Cyano-4-hydroxycinnamic acid supplier ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� α-Cyano-4-hydroxycinnamic acid vendor Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said. α-Cyano-4-hydroxycinnamic acid factory The United States has suspended imports of dogs from more than 100 countries where there’s a high rabies risk.